Penicillamine Other names: beta-Thiovaline D-Mercaptovaline D-Penamine D-Penicilamine D-Penicillamine D-Penicyllamine beta,beta-Dimethylcysteine Dimethylcysteine L-Penicillamine

Chemical formula: C₅H₁₁NO₂S Molecular mass: 149.211 g/mol PubChem compound: 5852

Therapeutic indications

Penicillamine is indicated for:

Indication

Population group: only children (1 year - 12 years old)

at least one of

Seropositive rheumatoid arthritis
Other rheumatoid arthritis
Juvenile rheumatoid arthritis

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Treatment 1

Indication

Population group: only adolescents (12 years - 18 years old) , adults (18 years old or older)

at least one of

Seropositive rheumatoid arthritis
Other rheumatoid arthritis
Juvenile rheumatoid arthritis

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Treatment 1

Indication

Population group: only adults (18 - 65 years old)

Disorders of copper metabolism

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Treatment 1

Indication

Population group: only children (1 year - 12 years old) , adolescents (12 years - 18 years old) , elderly (65 years old or older)

Disorders of copper metabolism

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Treatment 1

Indication

Population group: only adults (18 - 65 years old)

Disorders of amino-acid transport

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Treatment 1

Indication

Population group: only children (1 year - 12 years old) , adolescents (12 years - 18 years old) , elderly (65 years old or older)

Disorders of amino-acid transport

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Treatment 1

Indication

Population group: only adults (18 - 65 years old)

at least one of

Toxic liver disease with chronic active hepatitis
Chronic active hepatitis, not elsewhere classified
Primary biliary cirrhosis

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Treatment 1

Contraindications

Penicillamine is contraindicated in the following cases:

Contraindication

at least one of

Pregnancy
Lactation
Renal failure
Lupus erythematosus
Systemic lupus erythematosus
Idiopathic thrombocytopenic purpura
Other primary thrombocytopenia
Secondary thrombocytopenia
Thrombocytopenia, unspecified
Leukopenia
Gold preparations
Antimalarials
Antineoplastic agents

< Previous: Overview

Next: Precautions >

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.

⇈